Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022
Cash & Equivalents	8.4	0.03
Cash & Cash Equivalents	8.4	0.03
Cash Growth	25685.61%	-
Other Current Assets	0.09	0.7
Total Current Assets	8.49	0.73
Property, Plant & Equipment	0.02	0.04
Other Long-Term Assets	0	0.01
Total Long-Term Assets	0.03	0.05
Total Assets	8.52	0.78
Accounts Payable	0.17	0.4
Current Debt	0.02	0.07
Other Current Liabilities	0.64	0.86
Total Current Liabilities	0.83	1.33
Long-Term Debt	0	0.57
Other Long-Term Liabilities	0	4.42
Total Long-Term Liabilities	0	4.99
Total Liabilities	0.83	6.33
Total Debt	0.02	0.64
Debt Growth	-96.67%	-
Retained Earnings	-15.07	-6.71
Shareholders' Equity	7.69	-5.55
Net Cash / Debt	8.38	-0.61
Net Cash Per Share	0.62	-0.08
Working Capital	7.67	-0.61
Book Value Per Share	0.57	-0.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).